Lexicon Pharmaceuticals, Inc.
4 private offerings reported to the SEC on Form D since 2016, $181.3M sold in all. Pharma, Texas.
- Form D offerings: 4
- Reported sold: $181.3M
- Newest: Feb 17, 2026
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Feb 17, 2026 | — | $55.7M | $59.1M | Lexicon Pharmaceuticals, Inc.Pharma · Texas | Not amended | 0001193125-26-054545 |
| Jun 20, 2023 | — | $72.2M | $72.2M | Lexicon Pharmaceuticals, Inc.Pharma · Texas | Not amended | 0001209191-23-038406 |
| Aug 3, 2022 | — | $42.9M | $49.3M | Lexicon Pharmaceuticals, Inc.Pharma · Texas | Not amended | 0001209191-22-044197 |
| Mar 24, 2017 | — | $10.5M | $10.5M | Lexicon Pharmaceuticals, Inc.Pharma · Texas | Not amended | 0001062822-17-000022 |
- Ticker
- LXRX
- Business address
- The Woodlands, TX
- Incorporated in
- Delaware
- SEC industry
- Pharmaceutical Preparations
- Former names
- Lexicon Pharmaceuticals, Inc./De; Lexicon Genetics Inc/Tx
- All SEC filings
- CIK 1062822 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR